Warfarin sodium and Pletal drug interactions - from FDA reports


Summary

Drug interactions are reported among people who take Warfarin sodium and Pletal together. This review analyzes the effectiveness and drug interactions between Warfarin sodium and Pletal. It is created by eHealthMe based on reports of 710 people who take the same drugs from FDA, and is updated regularly.

What to expect?

If you take Warfarin sodium and Pletal, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Warfarin sodium and Pletal

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Warfarin Sodium

Warfarin sodium has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. (latest outcomes from Warfarin sodium 54,018 users)

Pletal

Pletal has active ingredients of cilostazol. It is often used in arteriosclerosis of the extremities. (latest outcomes from Pletal 5,780 users)

On Feb, 07, 2017

710 people who take Warfarin Sodium, Pletal are studied.


Number of reports submitted per year:

Warfarin sodium and Pletal drug interactions.

Most common drug interactions over time *:

< 1 month:
  • atrial fibrillation
  • cerebral infarction
  • sudden cardiac death
  • abdominal pain
  • dehydration
  • international normalised ratio increased
  • transient ischaemic attack
  • blood creatinine increased
  • blood urea increased
  • renal failure acute
1 - 6 months:
  • thrombosis
  • disseminated intravascular coagulation
  • renal failure acute
  • haematuria
  • haemolytic anaemia
  • platelet count decreased
  • renal impairment
  • thrombotic microangiopathy
  • cerebral infarction
  • chest pain
6 - 12 months:
  • disseminated intravascular coagulation
  • haematuria
  • haemolytic anaemia
  • platelet count decreased
  • renal failure acute
  • thrombosis
  • thrombotic microangiopathy
  • blood creatinine increased
  • dyspnoea
  • fall
1 - 2 years:
  • headache
  • renal impairment
  • urinary tract infection
  • abdominal pain
  • arthralgia
  • asthenia
  • blood creatinine increased
  • blood urea increased
  • chills
  • cholangitis
2 - 5 years:
  • anaemia
  • interstitial lung disease
  • bone marrow failure
  • gaze palsy
  • rash
  • electrocardiogram qt prolonged
  • torsade de pointes
  • ventricular tachycardia
  • atrioventricular block complete
  • electrocardiogram qt corrected interval prolonged
5 - 10 years:
  • disseminated intravascular coagulation
  • hepatic function abnormal
  • rhabdomyolysis
  • pneumonia
  • pyrexia
  • sudden death
  • anaemia
  • anal haemorrhage
  • atrial fibrillation
  • cerebrovascular disorder
not specified:
  • atrial fibrillation
  • dyspnoea
  • pain
  • anxiety
  • arthralgia
  • myocardial infarction
  • cardiac failure congestive
  • oedema peripheral
  • pneumonia
  • mitral valve incompetence

Most common drug interactions by gender *:

female:
  • atrial fibrillation
  • pain
  • anxiety
  • coronary artery disease
  • pain in extremity
  • haemoglobin decreased
  • anaemia
  • hypertension
  • international normalised ratio increased
  • dyspnoea
male:
  • atrial fibrillation
  • dyspnoea
  • pneumonia
  • cardiac failure congestive
  • headache
  • myocardial infarction
  • pain
  • arthralgia
  • oedema peripheral
  • anxiety

Most common drug interactions by age *:

0-1:
  • disseminated intravascular coagulation
  • hepatic function abnormal
  • rhabdomyolysis
  • pneumonia
  • pyrexia
  • fall
  • international normalised ratio increased
  • pelvic fracture
10-19:
  • back pain
  • dry gangrene
  • gastric disorder
  • syncope
20-29:
  • back pain
  • pneumonia
  • rhinitis allergic
  • dyslipidaemia
  • osteoporosis
  • abdominal pain upper
  • abscess
  • alcoholic liver disease
  • anaemia
  • aneurysm
30-39:
  • white blood cell count decreased
  • acute tonsillitis
  • constipation
  • cough
  • dental caries
  • dermatitis allergic
  • diarrhoea
  • dizziness
  • eczema
  • enterocolitis
40-49:
  • lymphoedema
  • venous thrombosis limb
  • pleural effusion
  • pulmonary embolism
  • thrombosis
  • cranial nerve palsies multiple
  • disseminated intravascular coagulation
  • haematuria
  • haemolytic anaemia
  • mononeuropathy multiplex
50-59:
  • nausea
  • diarrhoea
  • renal failure
  • pyrexia
  • disseminated intravascular coagulation
  • haemorrhage
  • metabolic acidosis
  • multi-organ failure
  • renal haemorrhage
  • decreased appetite
60+:
  • atrial fibrillation
  • asthenia
  • anaemia
  • dyspnoea
  • international normalised ratio increased
  • cardiac failure congestive
  • coronary artery disease
  • pain
  • anxiety
  • arthralgia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Warfarin sodium and Pletal?

Interactions between Warfarin sodium and drugs from A to Z

a b c d e f g h i j k l m n o p q r s t u v w x y z

Interactions between Pletal and drugs from A to Z

a b c d e f g h i j k l m n o p q r s t u v w x y z

On eHealthMe, Warfarin sodium (warfarin sodium) is often used to treat atrial fibrillation/flutter. Pletal (cilostazol) is often used to treat cerebral infarction. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:

Can you answer these questions?

More questions for: Warfarin sodium, Pletal

You may be interested in these reviews

More reviews for: Warfarin sodium, Pletal